CVKD filings
Corporate insider profile
Quang X Pham Filing Activity
Latest reported as Chairman, CEO and Interim CFO of Cadrenal Therapeutics, Inc. (CVKD).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$365,869.10
- Latest transaction
- Jun 26, 2026
Affiliated corporations
Reported company relationships
Transaction history